These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
186 related articles for article (PubMed ID: 31741333)
41. Transgenome transcription and replication in the liver and extrahepatic tissues of a human hepatitis B virus transgenic mouse. Choo KB; Liew LN; Chong KY; Lu RH; Cheng WT Virology; 1991 Jun; 182(2):785-92. PubMed ID: 2024497 [TBL] [Abstract][Full Text] [Related]
42. Molecular virology of hepatitis B virus and targets for antiviral intervention. Glebe D; König A Intervirology; 2014; 57(3-4):134-40. PubMed ID: 25034480 [TBL] [Abstract][Full Text] [Related]
43. Hepatitis B virus (HBV) virion and covalently closed circular DNA formation in primary tupaia hepatocytes and human hepatoma cell lines upon HBV genome transduction with replication-defective adenovirus vectors. Ren S; Nassal M J Virol; 2001 Feb; 75(3):1104-16. PubMed ID: 11152483 [TBL] [Abstract][Full Text] [Related]
44. The hepatitis B virus (HBV) HBx protein activates AKT to simultaneously regulate HBV replication and hepatocyte survival. Rawat S; Bouchard MJ J Virol; 2015 Jan; 89(2):999-1012. PubMed ID: 25355887 [TBL] [Abstract][Full Text] [Related]
45. Regulation of multiple stages of hepadnavirus replication by the carboxyl-terminal domain of viral core protein in trans. Liu K; Ludgate L; Yuan Z; Hu J J Virol; 2015 Mar; 89(5):2918-30. PubMed ID: 25540387 [TBL] [Abstract][Full Text] [Related]
46. T-cell therapy for chronic viral hepatitis. Bertoletti A; Tan AT; Koh S Cytotherapy; 2017 Nov; 19(11):1317-1324. PubMed ID: 28847469 [TBL] [Abstract][Full Text] [Related]
47. Biological characteristics of the A1762T/G1764A mutant strain of hepatitis B virus in vivo. Leng XH; Chen EQ; Du LY; Bai L; Gong DY; Cheng X; Huang FJ; Tang H Mol Med Rep; 2015 Oct; 12(4):5141-8. PubMed ID: 26165271 [TBL] [Abstract][Full Text] [Related]
48. Mapping of histone modifications in episomal HBV cccDNA uncovers an unusual chromatin organization amenable to epigenetic manipulation. Tropberger P; Mercier A; Robinson M; Zhong W; Ganem DE; Holdorf M Proc Natl Acad Sci U S A; 2015 Oct; 112(42):E5715-24. PubMed ID: 26438841 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of hepatitis B virus replication by targeting ribonucleotide reductase M2 protein. Liu X; Xu Z; Hou C; Wang M; Chen X; Lin Q; Song R; Lou M; Zhu L; Qiu Y; Chen Z; Yang C; Zhu W; Shao J Biochem Pharmacol; 2016 Mar; 103():118-28. PubMed ID: 26774458 [TBL] [Abstract][Full Text] [Related]
50. Experimental in vitro and in vivo models for the study of human hepatitis B virus infection. Allweiss L; Dandri M J Hepatol; 2016 Apr; 64(1 Suppl):S17-S31. PubMed ID: 27084033 [TBL] [Abstract][Full Text] [Related]
51. Latest developments in the treatment of hepatitis B. Dandri M; Petersen J Minerva Gastroenterol Dietol; 2016 Mar; 62(1):88-102. PubMed ID: 26448309 [TBL] [Abstract][Full Text] [Related]
52. The efficacy of zinc finger antiviral protein against hepatitis B virus transcription and replication in tansgenic mouse model. Chen EQ; Dai J; Bai L; Tang H Virol J; 2015 Feb; 12():25. PubMed ID: 25889209 [TBL] [Abstract][Full Text] [Related]
53. SIRT3 restricts hepatitis B virus transcription and replication through epigenetic regulation of covalently closed circular DNA involving suppressor of variegation 3-9 homolog 1 and SET domain containing 1A histone methyltransferases. Ren JH; Hu JL; Cheng ST; Yu HB; Wong VKW; Law BYK; Yang YF; Huang Y; Liu Y; Chen WX; Cai XF; Tang H; Hu Y; Zhang WL; Liu X; Long QX; Zhou L; Tao NN; Zhou HZ; Yang QX; Ren F; He L; Gong R; Huang AL; Chen J Hepatology; 2018 Oct; 68(4):1260-1276. PubMed ID: 29624717 [TBL] [Abstract][Full Text] [Related]
54. Effect of interferon alpha on hepatitis B virus replication and gene expression in transiently transfected human hepatoma cells. Rang A; Günther S; Will H J Hepatol; 1999 Nov; 31(5):791-9. PubMed ID: 10580575 [TBL] [Abstract][Full Text] [Related]
55. The Heteroaryldihydropyrimidine Bay 38-7690 Induces Hepatitis B Virus Core Protein Aggregates Associated with Promyelocytic Leukemia Nuclear Bodies in Infected Cells. Huber AD; Wolf JJ; Liu D; Gres AT; Tang J; Boschert KN; Puray-Chavez MN; Pineda DL; Laughlin TG; Coonrod EM; Yang Q; Ji J; Kirby KA; Wang Z; Sarafianos SG mSphere; 2018 Apr; 3(2):. PubMed ID: 29669885 [TBL] [Abstract][Full Text] [Related]
56. Mouse models of hepatitis B and delta virus infection. Dandri M; Lütgehetmann M J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647 [TBL] [Abstract][Full Text] [Related]
57. Requirement of the cyclic adenosine monophosphate response element-binding protein for hepatitis B virus replication. Kim BK; Lim SO; Park YG Hepatology; 2008 Aug; 48(2):361-73. PubMed ID: 18615500 [TBL] [Abstract][Full Text] [Related]
58. KNK437 Inhibits Replication and Transcription of the Hepatitis B Virus. Hu K; Huang Y; Mu J; Cheng Z; Zhu X Bing Du Xue Bao; 2017 Jan; 33(1):24-35. PubMed ID: 30702818 [TBL] [Abstract][Full Text] [Related]
59. Influence of mutations in the hepatitis B virus genome on virus replication and drug resistance--implications for novel antiviral strategies. Tacke F; Manns MP; Trautwein C Curr Med Chem; 2004 Oct; 11(20):2667-77. PubMed ID: 15544468 [TBL] [Abstract][Full Text] [Related]
60. Differential inhibition of nuclear hormone receptor-dependent hepatitis B virus replication by the small heterodimer partner. Oropeza CE; Li L; McLachlan A J Virol; 2008 Apr; 82(8):3814-21. PubMed ID: 18234786 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]